JoVE Logo
Faculty Resource Center

Sign In

Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System

DOI :

10.3791/3683-v

11:31 min

August 8th, 2012

August 8th, 2012

24,522 Views

1Department of Immunology, College of Medicine, Mayo Clinic

The chromium release assay, a common assay for detecting cytotoxic T cell activity, has several limitations. Using antigen-specific CD8 T cells and the human breast cancer tumor line, SKBR3, in the present article, an impedance-based approach was examined for the capability of detecting cell killing.

Tags

Cytotoxic Activity

-- Views

Related Videos

article

Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes

article

Determining the Phagocytic Activity of Clinical Antibody Samples

article

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

article

Cell-based Flow Cytometry Assay to Measure Cytotoxic Activity

article

Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.

article

Generation of Human Alloantigen-specific T Cells from Peripheral Blood

article

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

article

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

article

Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining

article

In Situ MHC-tetramer Staining and Quantitative Analysis to Determine the Location, Abundance, and Phenotype of Antigen-specific CD8 T Cells in Tissues

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved